Xpeng's robotics subsidiary Dogotix closed a nine hundred million dollar financing round that values the unit at six point three billion dollars, the largest private-equity check ever written for a Chinese robotics maker. The deal hands the electric-vehicle manufacturer fresh ammunition in its bid to take on Tesla in the race to commercialize humanoid machines.
The capital structure
Alibaba, Tencent, IDG and Gaorong Ventures committed a combined six hundred million dollars, while Xpeng itself pledged two hundred million. The lineup reads like a who's who of Chinese tech capital, and the sizing suggests the backers are pricing in a long runway before any humanoid product reaches meaningful revenue.
The quarterly backdrop
The raise landed the same day Xpeng reported a second-quarter net loss that widened one hundred seventy-nine percent from a year earlier to one point three four billion yuan, or about one hundred ninety-nine million dollars. Research and development spending jumped thirty-two point one percent, while revenue climbed eight percent to nineteen point seven billion yuan. The loss expansion coincides with the spending surge required to develop both autonomous driving stacks and the robotics platform simultaneously.
He Xiaopeng's stated ambition
"I believe Xpeng will not only build one of China's most valuable humanoid robotics companies, but also become a global leader in physical AI, spearheading the large-scale adoption and commercialisation of advanced general-purpose humanoid robots and autonomous driving technologies in China and overseas," the co-founder and chief executive said in the company statement. The rhetoric mirrors Tesla's Optimus narrative, though Xpeng is starting from a smaller vehicle base and a wider quarterly deficit.
What to watch next
The six point three billion dollar valuation sets a high bar for the next funding cycle. Investors will look for evidence that Dogotix can move beyond prototype demonstrations into low-volume manufacturing, and whether Xpeng's vehicle cash flow can sustain the dual R&D burden without further equity dilution. The Alibaba and Tencent stakes also raise questions about data and cloud integration terms that have not been disclosed.